Cargando…

Lentiviral-based anti-HIV therapeutic vaccine: design, preclinical studies and phaseI/II clinical trial preliminary results

Detalles Bibliográficos
Autores principales:	Bauche, Cécile, Rodriguez, Marie, Sarry, Emeline, Bejanariu, Ana, Sabbah-Petrover, Emmanuelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221022/ http://dx.doi.org/10.1186/1471-2334-14-S2-P81

Ejemplares similares

Design and development of a new lentiviral based anti-HIV therapeutic vaccine
por: Rodriguez, M, et al.
Publicado: (2012)

P17-20. Lentiviral vector-based vaccine against SIV infection and simian AIDS
por: Beignon, A, et al.
Publicado: (2009)

Dendritic cell nediated inhibition of lentiviral infection
por: Drake, A, et al.
Publicado: (2012)

Identifying features of the lentiviral genome crucial for the establishment of latency
por: Ziglio, Serena, et al.
Publicado: (2013)

Increased PD-1 expression in cynomolgus and rhesus macaques during lentiviral infection
por: Hokey, David A, et al.
Publicado: (2006)

P03-01. The relationship of envelope evolution to lentiviral persistence and vaccine efficacy
por: Craigo, JK, et al.
Publicado: (2009)

Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy
por: Albershardt, Tina C, et al.
Publicado: (2015)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
por: Sola, Caroline, et al.
Publicado: (2013)

P12-15. Replication enhancement of an alphaviral-lentiviral replicating chimeric particle (RCP) vaccine
por: Young, K, et al.
Publicado: (2009)

P19-40. Different forms of a lentiviral glycoprotein presented by bivalent measles virus vaccines
por: Heidmeier, S, et al.
Publicado: (2009)

Novel insights from structural analysis of lentiviral and gammaretroviral reverse transcriptases in complex with RNA/DNA hybrids
por: Le Grice, Stuart, et al.
Publicado: (2013)

Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer
por: Napoletano, Chiara, et al.
Publicado: (2013)

Interleukin-1 receptor antagonist lentiviral gene transfer to the murine knee joint ameliorates collagen-induced arthritis
por: van de Loo, FAJ, et al.
Publicado: (2005)

Mutational analysis of H5N1 hemagglutinins: identification of molecular determinants for efficient packaging into pseudotyped lentiviral particles
por: Tang, DJ, et al.
Publicado: (2011)

P05-01. Generation of a HI-viral packaging cell line as scaffolding for a lentiviral display system
por: Schilling, K, et al.
Publicado: (2009)

A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells
por: Albershardt, Tina C, et al.
Publicado: (2014)

Therapeutic drug monitoring of meropenem and piperacilin administered in continuous infusion. preliminary data
por: Miralbés Torner, M, et al.
Publicado: (2015)

Preclinical animal models of COPD
por: Vlahos, Ross
Publicado: (2013)

Nef variants from non-pathogenic lentiviral strains inhibit iron uptake through an AP2-dependent inhibition of transferrin endocytosis
por: Koppensteiner, Herwig, et al.
Publicado: (2013)

Educational intervention and HIV infection: preliminary results
por: Bregigeon, Sylvie, et al.
Publicado: (2010)

Metalloproteinase inhibitors as a potential therapeutic approach in multiple myeloma: a preliminary study
por: Pais, A Sofia, et al.
Publicado: (2010)

Experiences in the design and implementation of phase II trials in CLL
por: Cohen, Dena R, et al.
Publicado: (2011)

P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates
por: Pegu, A, et al.
Publicado: (2009)

A BCMA-specific CAR T cell produced with clinically scalable lentiviral and T cell manufacturing processes has potent anti-multiple myeloma activity
por: Garrett, Tracy E, et al.
Publicado: (2015)

Cyclophosphamide mechanism of action in preclinical tecemotide studies
por: Hance, Ken, et al.
Publicado: (2013)

Lost in translation? Bridging the preclinical / clinical divide
por: Baker, Mark, et al.
Publicado: (2012)

Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing
por: Cambon, Karine, et al.
Publicado: (2017)

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
por: Hilton, Traci, et al.
Publicado: (2014)

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
por: Sanborn, Rachel, et al.
Publicado: (2015)

T2-mapping and T1-mapping detect myocardial involvement inTako-Tsubo cardiomyopathy: a preliminary experience
por: Vermes, Emmanuelle, et al.
Publicado: (2015)

Intratumoral injections of G100 (synthetic TLR4 agonist) increase trafficking of lentiviral vector-induced antigen-specific CD8 T cells to the tumor microenvironment
por: Albershardt, Tina C, et al.
Publicado: (2015)

AB115. Effects of target gene expression on ex vivo differentiated mesenchymal stromal cells transfected by lentiviral vector with PDE5 of short hairpin RNA
por: Xiao, Heng-Jun, et al.
Publicado: (2016)

A phase II study of lenalidomide in patients with relapsed or refractory ATLL
por: Phillips, Adrienne A, et al.
Publicado: (2014)

Reported outcomes in phase II studies of newly-diagnosed pulmonary tuberculosis
por: Bonnett, Laura J, et al.
Publicado: (2015)

A probability of benefit (AUC) approach to phase II cancer trials
por: Silcocks, Paul
Publicado: (2015)

Brazilian multicentre study of Takayasu’s arteritis in children and adolescents – preliminary results of a clinical, imaging and therapeutic study
por: Terreri, Maria Teresa, et al.
Publicado: (2011)

Advancements in preclinical screening methods for artemisinins during pregnancy
por: Donegan, G, et al.
Publicado: (2010)

Preclinical to clinical translation of anti-PD-1 blockade
por: Hirsch, Heather, et al.
Publicado: (2015)

Preclinical test of a lentivirus-mediated RNAi gene therapy against HIV-AIDS in the humanized mouse model
por: Centlivre, Mireille, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_hunkpudkfp5n63oij30hspi1ui